Linked Data API

Show Search Form

Search Results

1125609
registered interest false more like this
date less than 2019-05-09more like thismore than 2019-05-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Heart Diseases more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what comparative estimate he has made of the number of emergency ambulance dispatches for coronary heart disease in affected areas in England during the pollution episode in April 2019 and (a) the expected average and (b) the average over the last five years. more like this
tabling member constituency Southampton, Test more like this
tabling member printed
Dr Alan Whitehead more like this
uin 252463 more like this
answer
answer
is ministerial correction false remove filter
date of answer remove filter
answer text <p>According to the Daily Air Quality Index, there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the UK between 7 and 8 April 2019 and between 15 and 25 April 2019. The figures for emergency ambulance dispatches relating to coronary heart disease in this period are not available in the format requested and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-05-17T12:30:27.897Zmore like thismore than 2019-05-17T12:30:27.897Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
62
label Biography information for Dr Alan Whitehead more like this
1125739
registered interest false more like this
date less than 2019-05-09more like thismore than 2019-05-09
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Voluntary Scheme for Branded Medicines Pricing and Access more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department has plans to involve patient organisations in setting the success factors for the 2019 Voluntary Scheme for Branded Medicines Pricing and Access as part of the first operational review meeting. more like this
tabling member constituency Carshalton and Wallington more like this
tabling member printed
Tom Brake more like this
uin 252468 more like this
answer
answer
is ministerial correction false remove filter
date of answer remove filter
answer text <p>The Department has engaged with patient organisations on multiple occasions as part of the negotiation and implementation of the voluntary scheme. The Department is currently working closely with NHS England and the Association of the British Pharmaceutical Industry to develop success factors for the 2019 voluntary scheme and will keep patient groups informed on progress.</p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-05-17T12:34:07.99Zmore like thismore than 2019-05-17T12:34:07.99Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
151
label Biography information for Tom Brake more like this
1125320
registered interest false more like this
date less than 2019-05-08more like thismore than 2019-05-08
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Asthma: Prescriptions more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of asthma prescription charges on lifelong asthma sufferers. more like this
tabling member constituency Romford more like this
tabling member printed
Andrew Rosindell more like this
uin 251955 more like this
answer
answer
is ministerial correction false remove filter
date of answer remove filter
answer text <p>The Department has made no such assessment.</p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
remove maximum value filtermore like thismore than 2019-05-17T12:34:53.31Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
1447
label Biography information for Andrew Rosindell more like this
1125399
registered interest false more like this
date less than 2019-05-08more like thismore than 2019-05-08
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Heart Diseases more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many emergency hospital admissions there were of people with coronary heart disease in affected areas in England during the pollution episode in April 2019; and what comparative assessment he has made of the figures for that period with the (a) expected average and (b) average over the last five years. more like this
tabling member constituency Tooting more like this
tabling member printed
Dr Rosena Allin-Khan more like this
uin 252073 more like this
answer
answer
is ministerial correction false remove filter
date of answer remove filter
answer text <p>According to the Daily Air Quality Index, there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April 2019 and between 15 and 25 April 2019. The figures for emergency hospital admissions relating to coronary heart disease in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-05-17T12:32:56.73Zmore like thismore than 2019-05-17T12:32:56.73Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4573
label Biography information for Dr Rosena Allin-Khan more like this
1124901
registered interest false more like this
date less than 2019-05-07more like thismore than 2019-05-07
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Nusinersen more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government what discussions they have had with (1) NICE, (2) NHS England, and (3) Biogen, on a Managed Access Agreement for Spinal Muscular Atrophy treatment, Spinraza. more like this
tabling member printed
Baroness Thomas of Winchester more like this
uin HL15576 more like this
answer
answer
is ministerial correction false remove filter
date of answer remove filter
answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN HL15577 more like this
question first answered
less than 2019-05-17T11:07:46.62Zmore like thismore than 2019-05-17T11:07:46.62Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
3785
label Biography information for Baroness Thomas of Winchester more like this
1124902
registered interest false more like this
date less than 2019-05-07more like thismore than 2019-05-07
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March. more like this
tabling member printed
Baroness Thomas of Winchester more like this
uin HL15577 more like this
answer
answer
is ministerial correction false remove filter
date of answer remove filter
answer text <p>Departmental officials are in regular contact with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England about a range of issues, including progress in discussions about a potential managed access agreement for Spinraza (nusinersen). Ministers have also held meetings with Biogen, NICE and NHS England on a number of occasions, at which the availability of Spinraza was discussed.</p><p>NHS England and NICE have made stakeholders and the public aware of the outcome of its appraisal committee meeting and NICE is now able to recommend the use of Spinraza for National Health Service patients in England, subject to a managed access agreement agreed between NHS England and Biogen. The final appraisal document will be published in due course.</p><p> </p> more like this
answering member printed Baroness Blackwood of North Oxford more like this
grouped question UIN HL15576 more like this
question first answered
less than 2019-05-17T11:07:46.673Zmore like thismore than 2019-05-17T11:07:46.673Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
3785
label Biography information for Baroness Thomas of Winchester more like this